FG‐4592 protected haematopoietic system from ionising radiation in mice
Immunology · 2024
DOI: 10.1111/imm.13797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2024. Verfasst von Yuedong Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Management, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Radiation-Protective Agents, Radiation, Ionizing, Apoptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Military Medical Science and Technology Youth Cultivation Program.
Abstract (Originalsprache)
Ionising radiation exposure can lead to acute haematopoietic radiation syndrome. Despite significant advancements in the field of radioprotection, no drugs with high efficacy and low toxicity have yet been approved by the Food and Drug Administration. FG‐4592, as a proline hydroxylase inhibitor, may play an important role in radioprotection of the haematopoietic system. Mice were peritoneal injected with FG‐4592 or normal saline. After irradiation, the survival time, body weight, peripheral blood cell and bone marrow cell (BMC) count, cell apoptosis, pathology were analysed and RNA‐sequence technique (RNA‐Seq) was conducted to explore the mechanism of FG‐4592 in the haematopoietic system. Our results indicated that FG‐4592 improved the survival rate and weight of irradiated mice and protected the spleen, thymus and bone marrow from IR‐induced injury. The number of BMCs was increased and protected against IR‐induced apoptosis. FG‐4592 also promoted the recovery of the blood system and erythroid differentiation. The results of RNA‐Seq and Western blot showed that the NF‐κB signalling pathway and hypoxia‐inducible factor‐1 (HIF‐1) signalling pathway were upregulated by FG‐4592. Meanwhile, RT‐PCR results showed that FG‐4592 could promote inflammatory response significantly. FG‐4592 exhibited radioprotective effects in the haematopoietic system by promoting inflammatory response and targeting the NF‐κB, HIF signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health and Management, Wenzhou Medical University, Wenzhou, China.
- Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
- Department of Radiation Oncology, Chinese PLA General Hospital, Beijing, China.
ORCID-Profile: Yuedong Wang
Förderung
- National Natural Science Foundation of China
- Military Medical Science and Technology Youth Cultivation Program
Zitieren
APA
Wang, Y., Cheng, Y., Zhang, P., Huang, D., Zhai, X., Feng, Z., Fang, D., Liu, C., Du, J., & Cai, J. (2024). FG‐4592 protected haematopoietic system from ionising radiation in mice. Immunology. https://doi.org/10.1111/imm.13797
Vancouver
Wang Y, Cheng Y, Zhang P, Huang D, Zhai X, Feng Z, et al. FG‐4592 protected haematopoietic system from ionising radiation in mice. Immunology. 2024. doi:10.1111/imm.13797
BibTeX
@article{Wang2024,
author = {Wang, Yuedong and Cheng, Ying and Zhang, Pei and Huang, Daqian and Zhai, Xuanlu and Feng, Zhenlan and Fang, Duo and Liu, Cong and Du, Jicong and Cai, Jianming},
title = {FG‐4592 protected haematopoietic system from ionising radiation in mice},
journal = {Immunology},
year = {2024},
doi = {10.1111/imm.13797}
}
EUVIMED